Remnant living cells that escape cell loss in late-stage tumors exhibit cancer stem cell-like characteristics

por Chen, Y-L, Wang, S-Y, Liu, R-S, Wang, H-E, Chen, J-C, Chiou, S-H, Chang, C A, Lin, L-T, Tan, D T W, Lee, Y-J
Publicado 2012

Trials without borders—decentralized trials and ensuring access to novel cancer therapies during a global pandemic

por Tan, A.C., Tan, T.J.Y., Saw, S.P.L., Lam, J.Y.C., Yap, Y.S., Lim, W.-T., Tai, D.W.M., Ng, M.C.H., Tan, D.S.W.
Publicado 2022

Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial

por Rodon Ahnert, J., Tan, D.S.-W., Garrido-Laguna, I., Harb, W., Bessudo, A., Beck, J.T., Rottey, S., Bahary, N., Kotecki, N., Zhu, Z., Deng, S., Kowalski, K., Wei, C., Pathan, N., Laliberte, R.J., Messersmith, W.A.
Publicado 2023

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

por Kaye, S, Aamdal, S, Jones, R, Freyer, G, Pujade-Lauraine, E, de Vries, E G E, Barriuso, J, Sandhu, S, Tan, D S-W, Hartog, V, Kuenen, B, Ruijter, R, Kristensen, G B, Nyakas, M, Barrett, S, Burke, W, Pietersma, D, Stuart, M, Emeribe, U, Boven, E
Publicado 2012

Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group

por Loong, H.H., Shimizu, T., Prawira, A., Tan, A.C., Tran, B., Day, D., Tan, D.S.P., Ting, F.I.L., Chiu, J.W., Hui, M., Wilson, M.K., Prasongsook, N., Koyama, T., Reungwetwattana, T., Tan, T.J., Heong, V., Voon, P.J., Park, S., Tan, I.B., Chan, S.L., Tan, D.S.W.
Publicado 2023